Patients’ preferences in periodontal disease treatment elicited alongside an IQWiG benefit assessment: a feasibility study

References

• Institute for Quality and Efficiency in Health CareGeneral methods version 5.0 Available from: https://www.iqwig.de/download/IQWiG_General_Methods_Version_%204-2.pdfAccessed July 10, 2017
   Google Scholar
• National Institute for Health and Care Excellence [webpage on the Internet]Guide to the methods of technology appraisal2013 Available from: https://www.nice.org.uk/process/pmg9/chapter/forewordAccessed July 25, 2017
   Google Scholar
• Canadian Agency for Drugs and Technologies in Health [webpage on the Internet]Methods and guidelines2009 Available from: https://www.cadth.ca/about-cadth/how-we-do-it/methods-and-guidelinesAccessed July 25, 2017
   Google Scholar
• Haute Autorité de santéA methodological guide-choices in methods for economic evaluation2015 Available from: https://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/choices_in_methods_for_economic_evaluation.pdfAccessed July 25, 2017
   Google Scholar
• Bundesministerium der Justiz und für Verbraucherschutz§ 130b Agreements between the central association of health insurance companies and pharmaceutical companies on reimbursement for drugs, prescription authorization1988 Available from: http://www.gesetze-im-internet.de/sgb_5/__130b.htmlAccessed October 29, 2018 German
   Google Scholar
• MühlbacherACJuhnkeCInvolving patients, the insured and the general public in healthcare decision makingZ Evid Fortbild Qual Gesundhwes2016110–1113644 German
   Google Scholar
• MühlbacherACJuhnkeCBeyerARGarnerSPatient-focused benefit-risk analysis to inform regulatory decisions: the European Union perspectiveValue Health201619673474027712699
   PubMed Web of Science ®Google Scholar
• Center for Devices and Radiological HealthPatient preference information – voluntary submission, review in premarket approval applications, humanitarian device exemption applications, and de novo requests, and inclusion in decision summaries and device labeling. Guidance for industry, food and drug administration staff, and other stakeholders2016 Available from: http://www.fda.gov/downloads/%20MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM446680.pdfAccessed August 29, 2016
   Google Scholar
• DannerMHummelJMVolzFIntegrating patients’ views into health technology assessment: analytic hierarchy process (AHP) as a method to elicit patient preferencesInt J Technol Assess Health Care201127436937522004779
   PubMed Web of Science ®Google Scholar
• MühlbacherACBridgesJFBethgeSPreferences for antiviral therapy of chronic hepatitis C: a discrete choice experimentEur J Health Econ201718215516526846922
   PubMed Web of Science ®Google Scholar
• PostmusDMavrisMHillegeHLIncorporating patient preferences into drug development and regulatory decision making: results from a quantitative pilot study with cancer patients, carers, and regulatorsClin Pharmacol Ther201699554855426715217
   PubMed Web of Science ®Google Scholar
• HoMPGonzalezJMLernerHPIncorporating patient-preference evidence into regulatory decision makingSurg Endosc201529102984299325552232
   PubMed Web of Science ®Google Scholar
• JanssenIMGerhardusASchröer-GüntherMAScheiblerFA descriptive review on methods to prioritize outcomes in a health care contextHealth Expect20151861873189325156207
   PubMed Web of Science ®Google Scholar
• GKV Spitzenverband [webpage on the Internet]AMNOG – evaluation of new pharmaceutical Available from: https://www.gkv-spitzenver-band.de/english/statutory_health_insurance/amnog_evaluation_of_new_pharmaceutical/amnog_english.jspAccessed January 23, 2018
   Google Scholar
• Institute for Quality and Efficiency in Health Care [webpage on the Internet]G0901 Health economic evaluation of venlafaxine, duloxetine, bupropion, and mirtazapine compared to further prescribable pharmaceutical treatments2013 Available from: https://www.iqwig.de/de/projekte-ergebnisse/projekte/gesundheitsoekonomie/g09-01-kosten-nutzen-bewertung-von-venlafaxin-duloxetin-bupropion-und-mirtazapin-im-vergleich-zu-weiteren-verordnungsfaehigen-medika-mentoesen-behandlungen.1256.htmlAccessed January 23, 2018
   Google Scholar
• de Bekker-GrobEWRyanMGerardKDiscrete choice experiments in health economics: a review of the literatureHealth Econ201221214517222223558
   PubMed Web of Science ®Google Scholar
• ClarkMDDetermannDPetrouSMoroDde Bekker-GrobEWDiscrete choice experiments in health economics: a review of the literaturePharmacoeconomics201432988390225005924
   PubMed Web of Science ®Google Scholar
• Bundesanzeiger VerlagLaw for the reorganization of the pharmaceutical market in the statutory health insurance (Arzneimittelmarktneuordnungs-gesetz – AMNOG)2010 Available from: http://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl110s2262.pdfAccessed October 29, 2018 German
   Google Scholar
• RydénAChenSFloodERomeroBGrandySDiscrete choice experiment attribute selection using a multinational interview study: treatment features important to patients with type 2 diabetes MellitusPatient201710447548728315192
   PubMedGoogle Scholar
• BridgesJFHauberABMarshallDConjoint analysis applications in health – a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task ForceValue Health201114440341321669364
   PubMed Web of Science ®Google Scholar
• Institute for Quality and Efficiency in Health CareGA1501 Präferenz-messung bei Parodontopathien2016 Available from: https://www.iqwig.de/download/GA15-01_Arbeitspapier_Praeferenzmessung-bei-Parodontopathien_V1-1.pdfAccessed July 25, 2017
   Google Scholar
• SavageAEatonKAMolesDRNeedlemanIA systematic review of definitions of periodontitis and methods that have been used to identify this diseaseJ Clin Periodontol200936645846719508246
   PubMed Web of Science ®Google Scholar
• ChappleILVan der WeijdenFDoerferCPrimary prevention of periodontitis: managing gingivitisJ Clin Periodontol201542Suppl 16S71S7625639826
   PubMed Web of Science ®Google Scholar
• Kassenzahnärztliche Bundesvereinigung [webpage on the Internet]Behandlung der Parodontitis Available from: http://www.kzbv.de/behandlung-der-parodontitis.97.de.htmlAccessed September 7, 2017
   Google Scholar
• Institute for Quality and Efficiency in Health Care [webpage on the Internet]N1501 Assessment of the systematic treatment of parodontopathies2015 Available from: https://www.iqwig.de/en/projects-results/projects/non-drug-interventions/n15-01-assessment-of-the-systematic-treatment-of-parodontopathies.6629.htmlAccessed July 19, 2017
   Google Scholar
• LeeCTHuangHYSunTCKarimbuxNImpact of patient compliance on tooth loss during supportive periodontal therapy: a systematic review and meta-analysisJ Dent Res201594677778625818586
   PubMed Web of Science ®Google Scholar
• BäumerAPretzlBCosgareaRTooth loss in aggressive periodontitis after active periodontal therapy: patient-related and tooth-related prognostic factorsJ Clin Periodontol201138764465121564157
   PubMed Web of Science ®Google Scholar
• EickholzPKaltschmittJBerbigJReitmeirPPretzlBTooth loss after active periodontal therapy. 1: patient-related factors for risk, prognosis, and quality of outcomeJ Clin Periodontol200835216517418199150
   PubMed Web of Science ®Google Scholar
• CostaFOLagesEJCotaLOLorentzTCSoaresRVCortelliJRTooth loss in individuals under periodontal maintenance therapy: 5-year prospective studyJ Periodontal Res201449112112823647520
   PubMed Web of Science ®Google Scholar
• CostaFOMiranda CotaLOPereira LagesEJProgression of periodontitis and tooth loss associated with glycemic control in individuals undergoing periodontal maintenance therapy: a 5-year follow-up studyJ Periodontol201384559560522769441
   PubMed Web of Science ®Google Scholar
• GilbertGHSheltonBJChaversLSBradfordEHPredicting tooth loss during a population-based study: role of attachment level in the presence of other dental conditionsJ Periodontol200273121427143612546092
   PubMed Web of Science ®Google Scholar
• HujoelPPLerouxBGDeRouenTAPowellLVKiyakHAEvaluating the validity of probing attachment loss as a surrogate for tooth mortality in a clinical trial on the elderlyJ Dent Res19977648588669126182
   PubMed Web of Science ®Google Scholar
• OrmeBKGetting Started with Conjoint AnalysisMadison, WIResearch Publishers LLC2006
   Google Scholar
• HensherDARoseJMGreeneWHApplied Choice Analysis: A PrimerCambridge University PressCambridge2005
   Google Scholar
• DalyLEBourkeGJInterpretation and Uses of Medical Statistics5th edOxford; Malden, MABlackwell Science2000
   Google Scholar
• HauberABGonzálezJMGroothuis-OudshoornCGStatistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task ForceValue Health201619430031527325321
   PubMed Web of Science ®Google Scholar
• ClarksonJERamsayCRAverleyPIQuaD dental trial; improving the quality of dentistry: a multicentre randomised controlled trial comparing oral hygiene advice and periodontal instrumentation for the prevention and management of periodontal disease in dentate adults attending dental primary careBMC Oral Health2013135824160246
   PubMed Web of Science ®Google Scholar
• TanSHXVernazzaCRNairRCritical review of willingness to pay for clinical oral health interventionsJ Dent20176411228662842
   PubMed Web of Science ®Google Scholar
• de Bekker-GrobEWDonkersBJonkerMFStolkEASample size requirements for discrete-choice experiments in healthcare: a practical guidePatient20158537338425726010
   PubMedGoogle Scholar
• BienDRDannerMVennedeyVCivelloDEversSMHiligsmannMPatients’ preferences for outcome, process and cost attributes in cancer treatment: a systematic review of discrete choice experimentsPatient201710555356528364387
   PubMedGoogle Scholar
• FlynnTNLouviereJJPetersTJCoastJEstimating preferences for a dermatology consultation using best-worst scaling: comparison of various methods of analysisBMC Med Res Methodol200887619017376
   PubMed Web of Science ®Google Scholar
• FlynnTNLouviereJJPetersTJCoastJBest – worst scaling: what it can do for health care research and how to do itJ Health Econ200726117118916707175
   PubMed Web of Science ®Google Scholar
• LancsarELouviereJFlynnTSeveral methods to investigate relative attribute impact in stated preference experimentsSoc Sci Med20076481738175317257725
   PubMed Web of Science ®Google Scholar
• MilteRRatcliffeJMillerMWhiteheadCCameronIDCrottyMWhat are frail older people prepared to endure to achieve improved mobility following hip fracture? A discrete choice experimentJ Rehabil Med2013451818623037892
   PubMed Web of Science ®Google Scholar
• DannerMVennedeyVHiligsmannMFauserSStockSFocus groups in elderly ophthalmologic patients: setting the stage for quantitative preference elicitationPatient201691475725726011
   PubMedGoogle Scholar
• VassCMPayneKUsing discrete choice experiments to inform the benefit-risk assessment of medicines: are we ready yet?Pharmacoeconomics201735985986628536955
   PubMed Web of Science ®Google Scholar